| Trial ID | NCT06395389 |
| Status | Recruiting |
| Condition | Cannabis Use Disorder |
| Intervention | Health Education (HealthEdu) |
Cannabis use disorder affects nearly 3 million emerging adults annually, yet evidence-based brief interventions remain limited for this critical developmental period. This trial addresses a significant gap in scalable, age-appropriate cannabis treatment options when early intervention could prevent progression to severe dependency.
This randomized controlled trial compares two brief interventions for potentially problematic cannabis use in emerging adults aged 18-25. The study employs a rigorous design with two 40-50 minute sessions separated by one week, followed by assessments at post-intervention, 1-month, and 3-month intervals. Biological validation through salivary THC and CBD testing accompanies self-report measures at all four timepoints. The trial is currently recruiting participants for this Phase II behavioral intervention study.
“If positive, this trial could provide me with evidence-based brief intervention protocols specifically validated for emerging adults with cannabis use concerns. Having structured, time-limited interventions with demonstrated efficacy would significantly enhance my ability to offer targeted early intervention before patterns become entrenched.”
💬 Join the Conversation
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
This trial item was assembled from normalized source metadata and pipeline scoring.
